The 20th Awaji International Forum on Infection and Immunity
Sep 7 - Sep 9, 2022Hybrid
You can search for presentations in this event.
SearchThe 20th Awaji International Forum on Infection and Immunity
Sep 7 - Sep 9, 2022Hybrid
You can search for presentations in this event.
SearchSearch Results(81)
[PL1-1]Secreted effectors of Toxoplasma gondii block interferon signaling to promote parasite survival during chronic infection.
○David Sibley(Departmnt of Molecular MIcrobiology, Washington University School of Medicine, St. Louis MO, USA)
[PL2-1]An entero-hepatic-biliary axis of innate immunity
○Matthew Waldor, Ting Zhang, Yuko Hasegawa(Department of Microbiology and Medicine, Harvard Medical School and Brigham & Women's Hospital, Boston, MA USA.)
[PL3-1]Pandemic Preparedness
○Sir Michael Houghton(Li Ka Shing Applied Virology Institute, University of Alberta, Canada)
[S1-1]The molecular basis of hemorrhagic fever virus-host interactions leading to aberrant host inflammatory response: a potential target for antiviral and therapeutics development
○Hideki Ebihara(Department of Virology 1, National Institute of Infectious Diseases)
[S1-2]Flexible usage of diverse cell death players protects against Intracellular infections.
○Marco J Herold1,2(1.Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, 2.Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia)
[S1-3]Single cell analysis to elucidate mechanisms underlying oncogenesis caused by HTLV-1
○Yorifumi Satou(Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan)
[S1-4]SARS-CoV-2 Biology and Countermeasure Development
○Pei-Yong Shi(University of Texas Medical Branch at Galveston)
[S1-5]Evolution of SARS-CoV-2
○Kei Sato(The Institute of Medical Science, The University of Tokyo, Japan)
[S2-1]Recognition of PLAMP by cell-autonomous immunity is important for anti-Toxoplasma host defense
○Masahiro YAMAMOTO1(1.Dept. of Immunoparasitology, RIMD, Osaka University, Japan, 2.Lab. of Immunoparasitology, IFReC, Osaka University, Japan, 3.CIDER, Osaka University, Japan)
[S2-2]Coxiella burnetii: Professor of Cell Biology
Robson Loterio1,2, Dario S. Zamboni2, ○Hayley J. Newton1(1.Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Australia, 2.School of Medicine of Ribeirao Preto, Department of Cellular and Molecular Biology, University of Sao Paulo, Brazil)
[S2-3]Molecular mechanism of neutralization of a pan-SARS-CoV-2 antibody and ACE2-receptor recognition by BA.4/5 variants
○Takao Hashiguchi(Institute for Life and Medical Sciences, Kyoto University, Japan)
[S2-4]Guanylate-binding proteins and inflammasome signalling
○Si Ming Man(The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.)
[S2-5]Ubiquitination of Rab5 as a Legionella PLAMP
○Kohei Arasaki(School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Japan)
[S3-1]Evolution of humoral immunity to mutating viruses
○Yoshimasa Takahashi(Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Japan)
[S3-2]Functional assessment of human antigen receptor repertoires at single-cell level to guide vaccine design
○Hedda Wardemann(German Cancer Research Center (DKFZ))
[S3-3]Host-pathogen interaction in SARS-CoV-2 infection
○Hisashi Arase1,2(1.Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, 2.Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University)
[S3-4]Zα-dependent cross-talk of ADAR1 and ZBP1 controls pathogenic interferon responses to self RNA
○Manolis Pasparakis(Institute for Genetics and Cologne Excellence Cluster on Ageing-Associated Diseases, University of Cologne, Cologne, Germany)
[S3-5]Regulation of plasma cell survival for long-term protection from pathogens
○Wataru Ise(Division of Microbiology and Immunology, Center for Infectious Disease Education and Research, Osaka University)
[S4-1]The Bartonella autotransporter BafA, a specific activator of VEGF receptor 2 that drives host vasoproliferation
○Kentaro Tsukamoto(Department of Microbiology, Fujita Health University School of Medicine)
[S4-2]Liver resident memory and immunity to liver-stage malaria
○William R Heath(Department of Microbiology and Immunology, The University of Melbourne)
[S4-3]New insights into the pathobiology of Clostridium botulinum enteric infection
○Yukako Fujinaga(Graduate School of Medical Sciences, Kanazawa University)
[S4-4]Delivery of single-domain antibodies into neurons using a chimeric toxin-based platform is therapeutic in mouse models of botulism
Shin-Ichiro Miyashita1, Jie Zhang1, Sicai Zhang1, Charles Shoemaker2, ○Min Dong1(1.Boston Children's Hospital / Harvard Medical School, 2.Department of Infectious Diseases and Global Health, Cummings School of Veterinary Medicine at Tufts University)
[S4-5]Host-pathogen interaction between bacteria and phages in intestine
○Satoshi Uematsu1,2(1.Department of Immunology and Genomics, Graduate School of Medicine, Osaka Metropolitan University, 2.Division of Metagenome Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo)
[S5-1]Exploring the applications of engineered bacteriophages for the prevention and treatment of bacterial infections.
○Kiga Kotaro1,2, Aa Haeruman Azam1, Shinjiro Ojima1, Azumi Tamura1,3, Wakana Yamashita1,4, Kohei Kondo1,5, Tomohiro Nakamura1,6, Koichi Watashi1, Yoshimasa Takahashi1, Xin-Ee Tan2, Longzhu Cui2(1.Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 2.Division of Bacteriology, Department of Infection and Immunity School of Medicine, Jichi Medical University, 3.The Graduate School of Frontier Sciences, The University of Tokyo, 4.School of Advanced Science and Engineering, Waseda University, 5.AMR Research Center, National Institute of Infectious Diseases, 6.School of Veterinary Medicine, Department of Veterinary Medicine, Rakuno Gakuen University)
[S5-2]Epigenetic Reprogramming in Host-Parasite Coevolution: The Toxoplasma Paradigm
○Mohamed-Ali HAKIMI1,2(1.IAB - Institute for Advanced Biosciences, University Grenoble Alpes, 2.INSERM U1209)
[S5-3]Molecular mechanisms of malaria transmission to mammals via mosquito vectors
○Tomoko Ishino(Tokyo Medical and Dental University, Department of Parasitology and Tropical Medicine)
[S5-4]Interferon-driven PIM1 kinase controls GBP1 activity and guards bystander cells against self-damage
Daniel Fisch1,2, Moritz M. Pfleiderer3, Fabian Wendt4,5, Eleni Anastasakou3, Xiangyang Liu3, Barbara Clough2, Samuel Lara-Reyna2, Vesela Encheva6, Ambrosius P. Snijder6, Hironori Bando7,8, Masahiro Yamamoto7,8, Avinash R. Shenoy9,10, Jason Mercer2, Bernd Wollscheid4,5, Wojtek P. Galej3, ○Eva-Maria Frickel1,2(1.Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK., 2.Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK., 3.European Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France., 4.Department of Health Sciences and Technology (D-HEST), ETH Zurich, Institute of Translational Medicine (ITM), Zurich, Switzerland., 5.Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., 6.Mass Spectrometry and Proteomics Platform, The Francis Crick Institute, London, UK., 7.Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan., 8.Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan., 9.MRC Centre for Molecular Bacteriology & Infection, Department of Infectious Disease, Imperial College London, London, UK., 10.The Francis Crick Institute, London, UK.)
[S5-5]A sex biased imbalance of T-follicular regulatory (Tfr) cells, T-peripheral helper (Tph) cells and extrafollicular B-cells correlates with antibody responses in COVID-19 patients
Jonas Norskov Sondergaard1, Janyerkye Tulyeu1, Ryuya Edahiro2,3, Yuya Shirai2,3, Yuta Yamaguchi2,4, Teruaki Murakami2,4, Takayoshi Morita2,4, Yasuhiro Kato2,4, Haruhiko Hirata2, Yoshito Takeda2, Daisuke Okuzaki5,6,9,10, Shimon Sakaguchi7,8, Atsushi Kumanogoh2,4,9,10, Yukinori Okada3,9,10,11,12,13, ○James Badger Wing1,14(1.Human Single Cell Immunology Team, CiDER, Osaka University, 2.Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan, 3.Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan., 4.Department of Immunopathology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan., 5.Laboratory of Human Immunology (Single Cell Genomics), WPI-IFReC, Osaka University, Suita, Japan., 6.Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Japan, 7.Laboratory of Experimental Immunology, WPI-IFReC, Osaka University, Suita, Japan., 8.Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan., 9.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan., 10.CiDER, Osaka University, Suita, Japan., 11.Laboratory of Statistical Immunology. WPI-IFReC, Osaka University, Suita, Japan., 12.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan., 13.Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., 14.Human Immunology (single cell immunology), WPI-IFReC, Osaka University)
[S6-1]To control and overcome infectious diseases by understanding Virus-Human Interaction Networks
○Yoshiharu Matsuura1,2(1.Center for Infectious Disease Education and Research (CiDER), Osaka University, 2.Research Institute for Microbial Diseases (RIMD), Osaka University)
[S6-2]Transcriptomic landscapes of whole lung cells after influenza virus infection in mouse
○Shinichiro Sawa1, Koizumi Shin-ichi1, Sumiya Eriko1, Noguchi Naoto1, Kojo Satoshi2(1.Research Center for Systems Immunology, Medical Institute of Bioregulation, Kyushu University, 2.Graduate School of Medicine, Kanazawa University)
[S6-3]Elucidating the heterogeneity and dynamics of infectious diseases with data-driven approach
○Eiryo Kawakami1,2,3(1.Institute for Advanced Academic Research (IAAR), Chiba University, 2.Graduate School of Medicine, Chiba University, 3.Advanced Data Science Project (ADSP), RIKEN)
[S6-4]Estimating Fluctuations in Cell State Dynamics and Predicting Fate Bifurcations UnderUsing Deep Learning
○Teppei Shimamura(Graduate School of Medicine, Nagoya University, Japan)
[S6-5]Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan
○Shingo Iwami(interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Japan)
[P-01]Characterization of the anti-mammarenavirus activity of phospholipase C-γ inhibitor U-73122
○Keita Mizuma1, Shuzo Urata2,3, Masaharu Iwasaki1,4(1.Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 2.National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki, Japan, 3.Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 4.Center for Infectious Disease Education and Research (CiDER), Osaka University, Japan)
[P-02]SARS-CoV-2 papain-like protease counteracts ISGylation-mediated antiviral activity by sequestering ISGylated viral nucleocapsid protein
○Takayuki Abe1, Rhamadianti Aulia Fitri1, Tomohisa Tanaka2, Kohji Moriishi2, Chikako Ono3, Yoshiharu Matsuura3, Ikuo Shoji1(1.Division of Infectious Disease Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan, 2.Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi, Japan, 3.Center for Infectious Diseases Education and Research (CiDER), Research Institute for Microbial Diseases (RIMD), Osaka University, Osaka, Japan)
[P-03]Evaluation of endothelial cell monolayer damage elicited by Ebola virus infection using iPS-derived vascular endothelial cells
○Murasaki Amano1,2,3, Yasuteru Sakurai1,3, Keiko Imamura4,5,6, Takayuki Kondo4,5,6, Haruhisa Inoue4,5,6, Jiro Yasuda1,2,3(1.National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Japan, 2.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 3.Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan, 4.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 5.iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Japan, 6.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Japan)
[P-04]SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response
○Shunya Tsuji1, Shohie Minami2, Rina Hashimoto3, Tatsuya Suzuki4, Miwa Sasai5, Shiho Torii6, Chikako Ono6, Shintaro Shichinohe7, Shintaro Sato2,8, Masahiro Yamamoto5,9,10, Tokiko Watanabe7,10, Yoshiharu Matsuura6,10, Kazuo Takayama3, Takeshi Kobayashi2,10, Toru Okamoto4, Eiji Hara1,9,10(1.Department of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University, 2.Department of Virology, Research Institute for Microbial Diseases, Osaka University, 3.Center for iPS Cell Research and Application, Kyoto University, 4.Division of Infectious Diseases, Institute for Advanced Co-Creation Studies, Osaka University, 5.Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, 6.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, 7.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, 8.Osaka City University Graduate School of Medicine, 9.Immunology Frontier Research Center, Osaka University, 10.Center for Infectious Disease Education and Research, Osaka University)
[P-05]Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses
○Tomokazu Tamura1,2, Shiho Torii1,3, Kentaro Kajiwara4, Itsuki Anzai1, Yoichiro Fujioka5, Kisho Noda2, Shuhei Taguwa3, Yuhei Morioka2,3, Rigel Suzuki2, Yuzy Fauzyah1, Chikako Ono1,3, Yusuke Ohba5, Masato Okada4, Takasuke Fukuhara1,2, Yoshiharu Matsuura1,3(1.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Japan, 3.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Japan, 4.Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Japan, 5.Department of Cell Physiology, Faculty of Medicine, Hokkaido University, Japan)
[P-06]Characterization of the Lamusara virus ovarian tumor domain protease
○Takehiro Ozeki1,2,3, Yasuda Jiro1,2,3(1.Department of Emerging Infectious Diseases, National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Japan, 2.Graduate School of Biomedical Sciences, Nagasaki University, Japan, 3.Department of Emerging Infectious Diseases, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan)
[P-07]Effects of point mutations in putative epitopes of dengue virus E protein on human monoclonal antibody binding
○Yoshihiro Samune1, Yokoyama Masaru2, Sasaki Tadahiro1, Koketsu Ritsuko1, Nakayama Emi1, Kotani Osamu2, Sato Hironori2, Shioda Tatsuo1(1.Research Institute for Microbial Diseases, Osaka University, 2.Pathogen Genomics Center, National Institute of Infectious Diseases)
[P-08]Analysis of the role of rotavirus NSP4 protein in viral replication and pathogenicity
○Tomohiro Kotaki, Nurdin Jeffery A., Kawagishi Takahiro, Sato Shintaro, Yamasaki Moeko, Nouda Ryotaro, Minami Shohei, Kanai Yuta, Kobayashi Takeshi(Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan)
[P-09]Identification of TACSTD2 as a host factor involved in rotavirus infection
○Moeko Yamasaki1, Yuta Kanai1, Rina Hamajima2, Tomohiro Kotaki1, Shohei Minami1, Ryotaro Nouda1, Takeshi Kobayashi1(1.Research Institute for Microbial Diseases, Osaka University, Osaka, 2.Graduate School of Bioagricultural Sciences, Nagoya University, Aichi)
[P-10]Molecular docking analysis of selected phytochemicals from Garcinia spp. on the SARS-CoV-2 spike protein receptor-binding domain and angiotensin-converting enzyme 2 complex
Heidi Rose B Del Rosario, ○Mariam C Recuenco(Institute of Chemistry, University of the Philippines Los Banos, Philippines)
[P-11]Intranuclear viral RdRp of Borna disease virus 1 interferes with host RNA maturation and metabolism.
○Miina Kaneko1, Ryo Komorizono1, Akiko Makino1,2, Keizo Tomonaga1,2,3(1.Laboratory of RNA Viruses, Institute for Life and Medical Sciences, Kyoto University, 2.Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, 3.Department of Molecular Virology, Graduate School of Medicine, Kyoto University)
[P-12]An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
○Yafei Liu1,2, Wataru Nakai1,2, Noriko Arase3, Masako Kohyama1,2, Hisashi Arase1,2(1.Research Institute for Microbial Diseases, Osaka University, Japan, 2.WPI Immunology Frontier Research Center, Osaka University, Japan, 3.Graduate School of Medicine, Osaka University, Japan)
[P-13]Development of a highly safe and effective live attenuated SARS-CoV-2 vaccine based on temperature sensitivity-associated mutations
○Shinya Okamura1,2, Akiho Yoshida1,2, Shiro Takekawa1, Hirotaka Ebina1,2,3(1.The Research Foundation for Microbial Disease of Osaka University, Suita, Osaka, Japan, 2.Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan, 3.6Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan)
[P-14]Establishment of a low-volume SARS-CoV-2 infection system in the hamster model
○Kosuke Takada1, Orba Yasuko2,3, Sawa Hirofumi2,3,4, Watanabe Tokiko1,5(1.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Japan., 2.Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Japan., 3.International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Japan., 4.Global Virus Network, United States of America., 5.Center for Infectious Disease Education and Research, Osaka University, Japan.)
[P-15]Identification of a novel bat alphacoronavirus in Sierra Leone by using multiple degenerate primers
○Shintaro Shichinohe1, Kosuke Takada1, Pascal Hingamp2, Yuriko Tomita3, Tadashi Maemura4, Alhaji U. N'jai5, Tohru Suzuki6, Yoshihiro Kawaoka4,7,8, Hisashi Endo9, Hiroyuki Ogata9, Tokiko Watanabe1(1.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Faculte de Sciences, Aix-Marseille Universite, France, 3.Research Center for Influenza and Respiratory viruses, National Institute of Infectious Disease, Japan, 4.Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, United States of America, 5.Department of Microbiology, College of Medicine and Allied Health Sciences and Department of Biological Sciences, Fourah Bay College, University of Sierra Leone, Sierra Leone, 6.Division of Viral Disease and Epidemiology, National Institute of Animal Health, National Agriculture and Food Research Organization (NARO), Japan, 7.The Reseaech Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Japan, 8.Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Japan, 9.Chemical Life Science, Institute for Chemical Research, Kyoto University, Japan)
[P-16]Characterization of an antibody that neutralizes a wide range of SARS-CoV-2 variants
○Itsuki Anzai1, Fujita Junso2,3, Ono Chikako1,4,5, Kosaka Yoichiro6, Miyamoto Yuki6, Shichinohe Shintaro1, Takada Kosuke1, Torii Shiho1,4, Taguwa Shuhei4,5, Suzuki Koichiro7, Makino Fumiaki2,8, Kajita Tadahiro6, Inoue Tsuyoshi3, Namba Keiichi2,9,10, Watanabe Tokiko1,5, Matsuura Yoshiharu1,4,5(1.Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Graduate School of Frontier Biosciences, Osaka University, Japan, 3.Graduate School of Pharmaceutical Sciences, Osaka University, Japan, 4.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan, 5.Center for Infectious Disease Education and Research (CiDER), Osaka University, Japan, 6.Bio Matrix Research, Inc., Japan, 7.The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Japan, 8.JEOL Ltd., Japan, 9.JEOL YOKOGUSHI Research Alliance Laboratories, Osaka University, Japan, 10.RIKEN Center for Biosystems Dynamics Research and Spring-8 Center, Japan)
81 results ( 1 - 50 )
- 1